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Eradication of Mycoplasma gallisepticum and M. synoviae from
a chicken flock by antimicrobial injections in eggs and chicks
Erradicação de Mycoplasma gallisepticum e M. synoviae de um plantel
de galinhas pela injeção de antimicrobianos em ovos e pintos
Elmiro Rosendo do Nascimento1, Maria da Graça Fichel do Nascimento2, Maria Wanda dos Santos3,
Paulo Genaro de Oliveira Dias4, Osvaldo de Almeida Resende4 & Rita de Cássia Figueira Silva3
ABSTRACT
A chicken breeding flock of 3,464 hens, naturally infected with Mvcoplasma gallisepticum (MG) and M. svnoviae
(MS), was subjected to a mycoplasma eradication scheme, based on antimicrobial treatment of eggs and their hatched day-
old chicks. The egg injection sites utilized were the air cell and the small end (albumen), and the antibiotics used were tylosin
at two different doses (3 mg or 5 mg per egg) and gentamicin (0.6 mg/egg). For the chicks treatment, a combination of spec-
tinomycin and lincomycin, diluted in dextrose-vitamin complex solution, was employed. The differences in hatchability for
the egg air cell-embryo (17.2%), egg small end (albumen)-3mg tylosin (72.4%) and egg small end (albumen)-5mg tylosin
(42.1%) injection procedures were significantly different by Chi-square analysis (p<0.0001).  Injection of antimicrobials into
the air cell resulted in the highest drop in hatchability, followed by tylosin dose of 5 mg plus 0.6 mg of gentamicin into the
egg small end, compromising the further genetic use of their hatched chickens. The best performance on hatchability (72.4%)
was obtained when preincubated eggs were injected into the albumen with a combination of 3 mg of tylosin plus 0.6 mg of
gentamicin. The difference in hatchability from 75.0% to 70.0% obtained, respectively, between lines A and B was not sta-
tistically significant. The F1 progenies from the antibiotic treated eggs stayed free from MG and MS until they reached the
age of 12 months, when they were eliminated and replaced by their respective F2 substitutes.
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RESUMO
Um plantel de galinhas reprodutoras com 3.464 fêmeas, infectadas naturalmente por Mvcoplasma gallisepticum
(MG) and M. svnoviae (MS), foi submetido a um processo de erradicação de micoplasma, com base no tratamento antimicrobiano
de ovos e de seus respectivos pintos de um-dia de idade. Os sítios de injeção utilizados foram a câmara de ar e a ponta fina
(albumina), sendo que os antimicrobianos usados foram tilosina em duas doses (3 mg ou 5 mg por ovo) e gentamicina (0,6mg/
ovo). Para o tratamento dos pintos, uma combinação de espectinomicina e lincomicina, diluidos numa solução dextrose-
complexo vitamínico, foi empregada. As diferenças em eclodibilidade para injeções na câmara de ar de cada ovo embrionado
(17,2%), na ponta fina do ovo (albumina)-3mg tilosina (72,4%) e na ponta fina do ovo (albumina)-5mg tilosina (42,1%)
foram significativamente diferentes pelo teste de Qui-quadrado (p<0.0001).  A injeção de antimicrobianos na câmara de ar
resultou na mais elevada queda de eclosão, seguida pela dose de 5,0 mg de tilosina mais 0,6 mg de gentamicina na ponta fina
do ovo, comprometendo utilizações genéticas futuras das galinhas nascidas desses ovos. O melhor desempenho em eclodi-
bilidade (72,4%) foi obtido quando ovos pre-incubados foram injetados na ponta fina com uma combinação de 3,0 mg de
tilosina mais 0,6 mg de gentamicina. A diferença em eclodibilidade de 75,0% para 70,0% obtida, respectivamente, entre as
linhas A e B não foi estatisticamente significante. As progênies F1 dos ovos tratados com antimicrobianos permaneceram
livres de MG e MS até a idade de 12 meses, quando foram eliminadas e substituídas por suas respectivas progênies F2.
Descritores: galinha, Mycoplasma gallisepticum, M. synoviae, egg and embryo treatment, antimicrobianos.
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INTRODUCTION
Mycoplasma gallisepticum (MG), responsible
for chronic respiratory disease (CRD), and M. svnoviae
(MS), that causes synovitis, are also the main cause of
airsacculitis in poultry [6,13]. MG and MS infections
can be transmitted horizontally (bird to bird), and ver-
tically (through the egg), hence, affecting the breeding
flocks [10]. The economic losses caused by mycoplas-
mosis are generally attributed to decreased laying per-
formance, increased mortality and carcass condemna-
tion rates, high medication cost, and synergistic effect
associated with diseases or other factors [3,6]. Eradica-
tion of mycoplasma, based on its elimination into the
egg, it is done without affecting the embryo develop-
ment and subsequent hatchability of the mycoplasma-
free progeny [3,5,6,9,14]. Informations on antimicro-
bial injection into the egg air cell, are found for chicken
[10,11], but with respect to egg small end (albumen)
it is found for turkey hatching eggs [1,5]. Published
studies on injection of chicken eggs to eliminate my-
coplasma are scarse, because this procedure is mostly
conducted within the commercial poultry premises [14].
Tylosin is very efficient against mycoplasmas, while
spectinomycin, lincomycin and gentamicin are broad-
spectrum anti-microbials that work, preferably, against
Enterobacteriaceae [8,9,15].
The objective of this study was to eradicate
MG and MS from two chicken genetic stock lines,
using procedures that included the injection of antibio-
tic into eggs, via small end and air cell, of MG and MS
infected chicken, combined with antimicrobial treat-
ment of day-old chicks, in order to provide an unbia-
sed breeding selection, due to these mycoplasmas.
MATERIALS AND METHODS
Chicken flock informations
The chickens used were from a genetic stock
of white-egg fowls (leghorn)1. When the egg treat-
ment began, there were 3,464 hens in the flock, which
were being used for genetic improvement research,
with age ranging from 45 to 53 weeks old (average
of 48 weeks), and a laying production ranging from
37.0% to 48.0% (average of 42.0%). They were kept
caged and artificially inseminated with semen from
about 350 caged males. Out of these 3,462 hens,
1,929 constituted a sort of primary breeding flock
(parent flock), which was divided into line “A” with
1,155 hens (father line) and line B with 774 (mother
line). The others 1,535 hens were crosses between
lines A and B, i.e., the multiplier breeding flock. These
hens were housed in seven different groups, three of
line A, two of line B, and two of A x B lines, of about
400 chickens, according to their exact ages. Prior to
the beginning of this eradication scheme, all hens
were tested for MG and MS infections by serum ag-
glutination reaction (SAR} and hemagglutination in-
hibition (HI), as described [12]. Isolation of MG and
MS in this flock was also accomplished [7,12], besi-
des the history informations on the diagnosis of other
disease [2].
Drugs and their doses used
For egg treatment, tylosin1 and gentamicin sulfa-
te2 were diluted in 85.0% saline. A volume of 0.1 mL
of saline solution with 3.0 mg or 5.0 mg of tylosin
and 0.6 mg of gentamicin was inoculated per egg.
Additionally, each day-old chick received a subcuta-
neous injection, containing 0.2 mL of a Linco-Spectin
solution3 (5.0 mg of lincomycin and 10 mg of specti-
nomycin); 0.05 mL of 5.0% dextrose solution, and
0.05 mL of vitamin complex4.
Injection procedures
The eggs in trays were carefully inspected and
dry-cleaned, whenever any dirt was seen on them.
They were put air cell up or down, according to the
chosen site of inoculation. The injection area of each
egg, i.e., air cell or small end, were disinfected with
iodine-alcohol solution applied gently with the help
of a swab. Following desinfection, egg shell holes
were made with a portable electric dentist drill5, at-
tempting not to damage the shell membrane. The drills
used were very small, and that made possible the abs-
tention of holes of 0.5-0.8 mm in diameter. An auto-
matic syringe6 of 1.0 mL with needle of 4 mm x 5
gauges in size was used to deliver the antimicrobial
solution into the drilled eggs. Between injections, the
needle was scoured in iodine-alcohol soaked gauze,
being the gauze exchanged whenever drying was
taking place. Albumen expressed during injection was
wiped from the injection site with the help of gauze
soaked in alcohol. After injection, the eggs holes were
sealed with melted paraffin wax.
The automatic syringe as described above with
needle of 5 mm x 10 gauges in size was used to inject
a solution of antimicrobial and dextrose-vitamin, sub-
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cutaneously, in the dorsal region of the neck of each
day-old chick.
Egg handling and treatment procedures
Eggs for each incubation/treatment batch were
collected daily during a two-weeks interval. After
each collection/day, the eggs were stored in a room
with controlled temperature and humidity, where
they received fumigation desinfection (formaldehyde
gas) once or twice. Thereafter, the eggs were sent
to the hatchery, located on the same premise, when
they were fumigated again.
Eggs were treated and incubated in seven
different batches, spaced about one week apart from
each other. The numbers of eggs treated, the num-
ber of batches per line, the egg injection sites, and
the combined doses of each antimicrobial used are
presented under results (Table 1). The incubator and
hatchery were cleaned thoroughly and disinfected
before receiving the treated eggs. All eggs were fu-
migated at the entrance of the incubation room, after
anti-microbial treatment, and when transferred to the
hatchery. Incubated eggs in trays were removed from
the incubation place, treated with antimicrobials, fu-
migated and immediately returned to their previous
location. Eggs subjected to preincubation treatment,
i.e., the albumen injected ones, were incubated about
two hours after finishing the injection procedure. The
eggs were subjected to candling prior to incubation,
and every four days from 4-17 post-incubation days,
for the elimination of un-fertile eggs and/or dead
embryos.
Management of the Fl Progenies
Not all hatched chicks were used for subse-
quent breeding purpose. All saved chicks were sub-
jected to sexing and most of the males were culled.
The selected chicks were put in a chicken house loca-
ted about 1,000 meters away from their mother hens,
where they stayed until about 100 days, being, then,
caged. By this time, their parents had already been
culled, slaughtered and marketed a month before. The
Fl progenies were placed in houses and cages that had
been cleaned, disinfected, and emptied for at least a
month before use. Biosecurity measures, which inclu-
ded control of personnel, ration, vehicles, fomites, etc.
were adopted.
Monitoring scheme
All pipped embryos from treated eggs were bled,
sacrificed, necropsied and inspected for air sac lesions.
All embryos with lesions, and only five without, from
each incubation batch were subjected to culturing for
mycoplasma isolation [7,12]. The sera obtained from
the pipped embryos were pooled in groups of five and
subjected to SAR and HI for MG and MS. SAR was
Table 1. Egg Parameters by Injection site and Treatment Procedure (0.6 mg of gentamicin plus tylosin at 3mg or 5mg).
1. One incubation with embryos, treated on the 8th incubation day, from line A hens.
2. Two incubations for line A eggs and two others for line B.
3. Two incubations with eggs from lines A x B hens.
4. Chi-square analysis, not significant (p=0.132)











deyaL 987 297,6 400,8 585,51
selitreF 715 721,6 675,7 022,41
dehctaH 98 634,4 491,3 917,7
ytilitreF %5.56 %2.09 %6.49 %2.19
)%(dna#,deppiP 4 )%0.8(7 )%9.2(721 )%6.5(081 )%0.4(413
ytilibahctaH 5 %2.71 %4.27 %1.24 %3.45
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performed with commercial antigens for MG7 and
MS7 and the HI was conducted with laboratory made
antigen9, with four hemagglutinating units, accord-
ing to standard procedures [6,12].
The F1 progenies were monitored for MG and
MS infections by serology (SAR and HI) and cultu-
ring. Culturing was performed on specimens from
birds that appeared dead, sick, and from those appa-
rently healthy, by the tracheal swab procedure [12].
Serology was performed when the chickens (100%
of them) were aging 2-3 months, 5-6 months and 11-
12 months (replacement time).
Statistical analysis
Chi Square test for heterogeneity with confiden-
ce interval of 95% [4] was used to compare the pro-
portions of hatched, pipped and unhatchad eggs from
the three treatment groups under trial, as well as to
investigate the genetic effect on hatchability, using
eggs injected in the small end, and under the same
antimicrobial dose (3 mg of tylosin plus 0.6 mg of
gentamicin), from lines A and B.
RESULTS
Of the 3,464 hens tested prior to the begin-
ning of the egg treatment, 3,118 (90.0%) and 2,078
(60.0%) were, respectively, positive for MG and MS
by SAR and HI. These and other untyped mycoplas-
monellosis. Non-bacterial diseases had also been diag-
nosed as coccidiosis, aspergillosis, Marek’s disease, Lym-
phoyd leukosis, Newcastle disease, and Infectious Bur-
sal Disease.
A total of 15,584 eggs with fertility rates ran-
ging from 65.5% to 94.6% were subjected to antimi-
crobial treatment, and data pertaining to fertility, and
hatching performance per treatment scheme (injection
site and dose of tylosin) is being presented (Table 1).
The hatchability for the air cell treated embryos (8-
days of incubation) was drastically smaller (χ2 analy-
zes, p<0.0001) than that obtained for the small end,
i.e., albumen site of preincubated eggs (Table 1). Increa-
sing the tylosin dose from 3 mg to 5 mg reduced the
hatchability from 72.4% to 42.1%, difference also statis-
tically significant (p<0.0001) by χ2 analyzes (Table 1).
The treatment scheme used, had no effect on pipped
embryo frequency (Table 1).
The effect of the antimicrobial treatment, by
the albumen route, on chickens from the lines A and
B was investigated by χ2 analyzes, but there was no
statistical differences (table 2), although the hatcha-
bilities obtained was 75.0% for line A, and 70.0% for
line B (Table 2).
DISCUSSION
The antimicrobial egg treatment scheme de-
scribed herein, which included the treatment of day-
old chicks and biosecu-
rity measures, was suf-
ficient for the obtention
of MG and MS-free chi-
ckens with only one ap-
plication.
Tylosin was used
because of its proven ef-
ficiency against myco-
plasmas [8,15] and gen-
tamicin was used because of its broad-spectrum activi-
ty against bacteria and its low toxicity to host cells [15].
The use of gentamicin was justified also by the infor-
mation on bacterial diseases, including non-pullorum
salmonellosis, diagnosed in this genetic flock in pre-
vious years. Tylosin can be toxic for eggs when used
in high doses as evidenced by the drop in hatchability,
observed when the dose of this antibiotic was increased
from 3 mg to 5 mg/egg.
The positive reactions obtained for sera from
pipped embryos on the HI test can be explained by the
mas had been isolated from necropsied birds from this
flock several times in the past, prior to this eradica-
tion trial. The diagnosis of Chronic Respiratory Disea-
se (CRD) and/or Airsacculitis with and without the pos-
sible involvement of Escherichia coli was also obtai-
ned in necropsied chickens, culled prior to this anti-
microbial treatment trial.
As to the records of other diseases that were
diagnosed in previous years, informations were availa-
ble on other bacterial diseases, such as Infectious Cory-
za (Haemophilus parallinarum) and non-pullorum sal-
Table 2. Effect of egg treatment (3.0 mg of tylosin plus 0.6 mg of gentamicin) on two chicken lines1
1. Eggs injected into albumen.
2. Chi-square analysis, not significant (p=0.429).
)%(dnarebmun,sretemarapggE
detabucnIeniL selitreF dehctaH deppiP ytilitreF ytilibahctaH 2
A 754,3 899,2 742,2 66 )0.78( )0.57(
B 515,3 921,3 981,2 16 )0.98( )0.07(
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presence of maternal antibodies transmitted from hens
to their eggs. The use of uninoculated eggs to serve as
a control group was not employed due to the risk of
compromising the eradication scheme adopted. The va-
riation in fertility rates observed on different incubation
batches of eggs may be explained by the way these
hens were fertilized, i.e., by artificial insemination.
The better hatchability results obtained for
eggs treated in the small end (albumen) over the air
cell route has also been observed in the case of tur-
key eggs [5]. Because of the drastic mortality of em-
bryos treated by the air cell route, this procedure was
discontinued and the chicks hatched were not saved
for breeding purposes. Besides, chicks hatched from
eggs treated with 5 mg of tylosin, due also to high
mortality, were not saved for breeding purposes, due
to the fear of loosing genetic variability, hence, com-
promising future crossings.
The antimicrobial treatment of eggs alone
should not be judged responsible for the success of
this eradication scheme, as day-old chick antibiotic
treatment, biosecurity, and flock monitoring were also
adopted. With the eradication of MG and MS, the ge-
netic selection and breeding improvement can be car-
ried out in this chicken genetic stock without the nega-
tive effects caused by the presence of MG and MS
infections.
CONCLUSION
Antimicrobial treatment of preincubated eggs
at the small end (albumen), in conjunction with treat-
ment day-old chicks hatched from treated eggs, was
sufficient to eliminate MG and MS from a genetic chi-
cken stock flock with only one application.
SOURCES AND MANUFACTURERS
1Experimental Station of Rio de Janeiro State Research Agri-
cultural Organization-PESAGRO/RIO, Itaguai, RJ, Brazil.
2Tylosin – “Tylan Soluvel, Elanco Quimica LTDA/Eli Lilly
do Brasil LTDA, São Paulo, SP, Brasil”.
3Gentamicin Sulfate – Gentocin ,“Industria Química e Far-
macêutica Schering S/A, Rio de Janeiro, RJ, Brasil”.
4Linco-Spectin solution – TUCO, “Divisão de Upjohn Pro-
dutos Farmacêuticos LTDA, São Paulo, SP, Brasil”.
5Vitamin Complex – “Poli Vitaminico SM-Forte, Laboratório
Santa Marina”, Brasil”.
6Electric dentist drill – Dentalwerk Burmoos, GES. M.B.H.,
Salzburg, Austria.
7Automatic syringe – FHK PISTOR 1-FJ-96, Fujihira Industry
Co. Inc., Japan.
8Commercial antigens for MG and MS – BIOVET S/A, Vargem
Grande Paulista, SP, Brazil.
9Projeto Saúde Animal (PSA)/Embrapa Agrobiologia, Sero-
pédica, RJ, Brazil.
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